Houston, TX -- (SBWIRE) -- 03/05/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Lorillard Inc.(NYSE:LO) added 0.31% and is trading at $38.32. Lorillard, Inc. (Lorillard) is the manufacturer of cigarettes in the United States. Its Newport is a menthol flavored premium cigarette brand. During the year ended December 31, 2011, the Newport brand accounted for approximately 88.4% of its sales revenue. In addition to the Newport brand, its product line has four additional brand families marketed under the Kent, True, Maverick and Old Gold brand names.
Can LO Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Cree, Inc.(NASDAQ:CREE) jumped 14.36% and is trading at $51.14. Cree, Inc. (Cree) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN) and related compounds. It focuses its expertise in SiC and GaN on light emitting diode (LED) products. It develops lighting-class light emitting diode (LED) products, lighting products and semiconductor products for power and radio-frequency (RF) applications.
How Should Investors Trade CREE After The Recent Volatile Moves? Find Out Here
Ascena Retail Group Inc(NASDAQ:ASNA) is higher 14.04% and is trading at $18.85. Ascena Retail Group, Inc. (Ascena) is a national specialty retailer of apparel for women and tween girls operating, through its wholly owned subsidiaries, the dressbarn, maurices, and Justice brands. As of July 28, 2012, the Company operated over 3,800 stores throughout the United States, Puerto Rico and Canada.
Is ASNA Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
Anthera Pharmaceuticals Inc(NASDAQ:ANTH) gained 12.96% and is trading at $0.645. Anthera Pharmaceuticals, Inc. (Anthera) is a development-stage, biopharmaceutical Company focused on developing and commercializing products to treat diseases associated with inflammation. As of December 31, 2011, the Company had one Phase-II clinical program, blisibimod.
Can ANTH Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)